Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe cholestatic liver injury days after initiating antiretroviral therapy in a patient with AIDS: drug toxicity or immune reconstitution inflammatory syndrome?

× No keyword cloud information.

25 in total

1. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Authors: M S Sulkowski; D L Thomas; R E Chaisson; R D Moore
Journal: JAMA Date: 2000-01-05 Impact factor: 56.272

2. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

Authors: M John; J Flexman; M A French
Journal: AIDS Date: 1998-12-03 Impact factor: 4.177

3. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

Authors: M A French; N Lenzo; M John; S A Mallal; E J McKinnon; I R James; P Price; J P Flexman; M L Tay-Kearney
Journal: HIV Med Date: 2000-03 Impact factor: 3.180

4. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Authors: Mark S Sulkowski; David L Thomas; Shruti H Mehta; Richard E Chaisson; Richard D Moore
Journal: Hepatology Date: 2002-01 Impact factor: 17.425

5. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.

Authors: Y Benhamou; V Di Martino; M Bochet; G Colombet; V Thibault; A Liou; C Katlama; T Poynard
Journal: Hepatology Date: 2001-08 Impact factor: 17.425

6. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

Authors: E M Race; J Adelson-Mitty; G R Kriegel; T F Barlam; K A Reimann; N L Letvin; A J Japour
Journal: Lancet Date: 1998-01-24 Impact factor: 79.321

Severe cholestatic liver injury days after initiating antiretroviral therapy in a patient with AIDS: drug toxicity or immune reconstitution inflammatory syndrome?

1. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

2. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

3. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

4. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

5. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.

6. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

7. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.

8. Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients.

9. Hepatic granulomas: a 10 year single centre experience.

10. Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.

1. The Correlated Risk Factors for Severe Liver Damage Among HIV-Positive Inpatients With Abnormal Liver Tests.